Related Experiment Video

Updated: Aug 17, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

[RNA interference inhibits replication and expression of hepatitis B virus in mice]

Ying Wu1, Ai-long Huang, Ni Tang

  • 1Institute for Viral Hepatitis, Chongqing University of Medical Sciences, Chongqing 400010, China.

Zhonghua Yi Xue Za Zhi
|June 14, 2005
PubMed
Abstract

Insights

RNA interference effectively inhibits hepatitis B virus (HBV) replication in a novel mouse model. This study establishes a valuable tool for HBV research and demonstrates the potential of RNAi as an antiviral therapy.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Context:

  • Hepatitis B virus (HBV) infection remains a significant global health concern.
  • The lack of suitable animal models has hindered research into HBV pathogenesis and treatment.
  • RNA interference (RNAi) presents a promising therapeutic strategy for viral infections.

Purpose:

  • To establish a mouse model for acute hepatitis B virus (HBV) infection.
  • To evaluate the efficacy of RNA interference (RNAi) in inhibiting HBV replication and gene expression within this model.

Summary:

  • A mouse model of acute HBV infection was developed using hydrodynamic injection of a HBV plasmid.
  • RNA interference, specifically using short hairpin RNA targeting HBV, significantly reduced viral markers (HBsAg, HBcAg, and HBV C mRNA).
  • Control groups, including a mutant RNAi vector and an irrelevant siRNA, showed less effective inhibition compared to specific RNAi.

Impact:

  • Successfully established a functional mouse model for acute HBV infection, addressing a critical research gap.
  • Demonstrated the specific and effective inhibitory potential of RNAi against HBV replication and expression.
  • Highlights the potential of siRNA as a novel antiviral therapeutic agent for hepatitis B.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...